Granules India Completes Acquisition of Senn Chemicals
ECONOMY & POLICY

Granules India Completes Acquisition of Senn Chemicals

Granules India Ltd. has officially closed the acquisition of Senn Chemicals AG, a Switzerland-based CDMO specialising in peptide development and manufacturing. This strategic move marks Granules’ entry into the peptide therapeutics segment and contract development and manufacturing (CDMO) services, bolstering its innovation-led growth strategy. 

The acquisition, executed through Granules’ wholly owned subsidiary Granules Peptides Pvt. Ltd., involves a 100% equity stake purchase from the founding Senn family. 

Headquartered in Dielsdorf, Switzerland, Senn Chemicals brings over six decades of expertise in Liquid-Phase and Solid-Phase Peptide Synthesis (LPPS & SPPS), serving pharmaceutical, cosmetic, amino acid derivative (AAD), and theragnostic markets. 

Dr. Krishna Prasad Chigurupati, Chairman and MD of Granules India, highlighted the deal as a “pivotal step” in the company’s evolution into a science- and innovation-led enterprise. He emphasised the synergy between Senn’s peptide specialisation and Granules’ global manufacturing capabilities to drive high-quality, next-gen treatments in areas such as GLP-1 receptor agonists, anti-diabetic, and anti-obesity therapies. 

The acquisition also marks Granules’ formal entry into the CDMO sector, enhancing its global footprint with access to regulated markets, top-tier European scientific talent, and advanced R&D capabilities. Joint development initiatives in peptide APIs are already underway, with an expanded pipeline in the works. 

Advisors on the deal included Stifel Nicolaus India (financial), Loyens & Loeff (legal), Deloitte (financial and tax diligence), and Kroll (valuation). 

This acquisition strengthens Granules’ innovation capabilities and positions it as a key player in the rapidly growing complex therapeutics and CDMO markets. 


(BSE)     

Granules India Ltd. has officially closed the acquisition of Senn Chemicals AG, a Switzerland-based CDMO specialising in peptide development and manufacturing. This strategic move marks Granules’ entry into the peptide therapeutics segment and contract development and manufacturing (CDMO) services, bolstering its innovation-led growth strategy. The acquisition, executed through Granules’ wholly owned subsidiary Granules Peptides Pvt. Ltd., involves a 100% equity stake purchase from the founding Senn family. Headquartered in Dielsdorf, Switzerland, Senn Chemicals brings over six decades of expertise in Liquid-Phase and Solid-Phase Peptide Synthesis (LPPS & SPPS), serving pharmaceutical, cosmetic, amino acid derivative (AAD), and theragnostic markets. Dr. Krishna Prasad Chigurupati, Chairman and MD of Granules India, highlighted the deal as a “pivotal step” in the company’s evolution into a science- and innovation-led enterprise. He emphasised the synergy between Senn’s peptide specialisation and Granules’ global manufacturing capabilities to drive high-quality, next-gen treatments in areas such as GLP-1 receptor agonists, anti-diabetic, and anti-obesity therapies. The acquisition also marks Granules’ formal entry into the CDMO sector, enhancing its global footprint with access to regulated markets, top-tier European scientific talent, and advanced R&D capabilities. Joint development initiatives in peptide APIs are already underway, with an expanded pipeline in the works. Advisors on the deal included Stifel Nicolaus India (financial), Loyens & Loeff (legal), Deloitte (financial and tax diligence), and Kroll (valuation). This acquisition strengthens Granules’ innovation capabilities and positions it as a key player in the rapidly growing complex therapeutics and CDMO markets. (BSE)     

Next Story
Real Estate

Parsvnath, Unity Group Open Luxury Mall ‘Unity One Elegante’

Parsvnath Developers Limited, one of India’s leading real estate and infrastructure companies, has announced the completion of its luxury shopping mall, ‘Unity One Elegante’, located at Netaji Subhash Place, Delhi. The project has been developed through Unity Parsvnaths LLP, a joint venture between Parsvnath Developers and Unity Group.The company has received the Occupancy-cum-Completion Certificate from the Delhi Development Authority (DDA), confirming that construction of the mall is complete. The facility is set to open and become operational soon.Developed on 28,400 square metres of ..

Next Story
Infrastructure Urban

Balu Forge Starts Precision Machining Line In Belgaum

Balu Forge Industries Ltd (Balu Forge), a precision engineering firm specialising in forged and machined components, has commenced operations of its new precision machining line at the company’s manufacturing campus in Belgaum, Karnataka. The facility features 7-Axis and 11-Axis CNC machines, marking one of the first such advanced installations in the region.The new line significantly enhances Balu Forge’s ability to deliver high-precision machining solutions for critical sectors such as railways, defence, aerospace, and other precision industries. It enables the manufacture of complex com..

Next Story
Infrastructure Urban

RMC Switchgears H1 Sales Double To Rs 2.21 Billion

RMC Switchgears Limited has reported unaudited sales of Rs 2.21 billion for the first half of the financial year 2025–26 (April to September), compared with Rs 1.05 billion in the same period of FY2024–25 — a robust year-on-year growth of over 110 per cent.The strong performance was primarily driven by the Solar EPC segment, which contributed approximately Rs 1.14 billion to total revenue. The Electrical EPC and Electrical Products segments followed, contributing Rs 570 million and Rs 500 million, respectively.The continued momentum in the Solar EPC business highlights the strategic rele..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?